Acerus Pharmaceuticals Corporation's stock has declined approximately -85.14324% over the past 52 weeks. The 50-day moving average sits at 0.56, while the 200-day moving average is 1.71.
| Beta (5Y) | N/A |
| 52-Week Price Change | -85.14324% |
| 50-Day Moving Average | 0.56 |
| 200-Day Moving Average | 1.71 |
| Average Volume (20 Days) | N/A |
Acerus Pharmaceuticals Corporation's most recent stock split took place on April 29, 2022 with a 200:1 split ratio.
| Last Split Date | 4/29/2022 |
| Split Ratio | 200:1 |